TOPLINE: Increased lithium exposure in drinking groundwater was associated with a reduced risk for cancer, according to findings from a US study. The protective effect was […]

TOPLINE: Breast cancer survivors who received chemotherapy, endocrine therapy, or both showed a significant decline in physical health during the first 2 years after diagnosis compared […]

TOPLINE: Less than half of patients with localized colorectal cancer completed their planned capecitabine and oxaliplatin (CAPOX) chemotherapy cycles, with female patients showing particularly poor tolerability. […]

TOPLINE: In patients with hormone receptor (HR)–positive, human epidermal growth factor receptor 2 (ERBB2)–negative metastatic breast cancer who progressed following endocrine plus cyclin-dependent kinase 4 and […]

TOPLINE: European adolescents and young adults (AYAs) aged 15-39 years had lower 5-year relative survival (RS) rates than children for most types of leukaemia and lymphoma, […]

TOPLINE: Early clearance of measurable residual disease (MRD) after induction therapy in patients with acute myeloid leukemia (AML) is associated with significantly better relapse-free survival (RFS) […]

TOPLINE: One in 6 patients in phase 2 cancer trials received treatments that were eventually approved by the US Food and Drug Administration (FDA), a new […]